The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of single agent pan-HER inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer (sSCC).
 
Paolo Bossi
Honoraria - MSD Oncology; Prostrakan; Roche
Consulting or Advisory Role - Helsinn Therapeutics; Merck Serono; Mundipharma; Onxeo
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Exelixis (Inst); Helsinn Therapeutics (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
 
Stefano Cavalieri
No Relationships to Disclose
 
Federica Perrone
No Relationships to Disclose
 
Rosalba Miceli
No Relationships to Disclose
 
Paolo Antonio Ascierto
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
 
Laura D. Locati
No Relationships to Disclose
 
Cristiana Bergamini
No Relationships to Disclose
 
Roberta Granata
No Relationships to Disclose
 
Salvatore Alfieri
No Relationships to Disclose
 
Carlo Resteghini
No Relationships to Disclose
 
Donata Galbiati
No Relationships to Disclose
 
Adele Busico
No Relationships to Disclose
 
Nicholas Paielli
No Relationships to Disclose
 
Roberto Patuzzo
No Relationships to Disclose
 
Andrea Maurichi
No Relationships to Disclose
 
Gianfranco Gallino
No Relationships to Disclose
 
Roberta Ruggeri
No Relationships to Disclose
 
Luigi Mariani
No Relationships to Disclose
 
Marco Palla
No Relationships to Disclose
 
Lisa Licitra
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Eisai; Merck Serono; MSD; Novartis; Roche; SOBI
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Debiopharm Group; Merck Serono; SOBI